Cibc World Market Inc. Enanta Pharmaceuticals Inc Transaction History

Cibc World Market Inc.

  • $48 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2018

Nov 09, 2018
SELL
$85.46 - $126.37 $1.91 Million - $2.83 Million
-22,391 Closed
0 $0
Q2 2018

Aug 08, 2018
BUY
$81.85 - $120.51 $1.5 Million - $2.2 Million
18,293 Added 446.39%
22,391 $2.6 Million
Q1 2018

May 18, 2018
BUY
$57.91 - $92.15 $237,315 - $377,630
4,098 New
4,098 $332,000

Others Institutions Holding ENTA

# of Institutions
110
Shares Held
21.1M
Call Options Held
4.8K
Put Options Held
4.6K
View Full List

About ENANTA PHARMACEUTICALS INC

ENTA Quotes by TradingView
  • Ticker ENTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,724,900
  • Market Cap $145M
  • Description
  • Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...
More about ENTA
Track This Portfolio

Track Cibc World Market Inc. Portfolio

Follow Cibc World Market Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc World Market Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cibc World Market Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email